لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Foster CC; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee. corey.c.foster@vumc.org schmura@radonc.uchicago.edu lukejj@upmc.edu., Fleming GF; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois., Karrison TG; Department of Public Health Sciences, The University of Chicago, Chicago, Illinois., Liao CY; Department of Public Health Sciences, The University of Chicago, Chicago, Illinois., Desai AV; Department of Pediatrics, Section of Hematology, Oncology, and Stem Cell Transplantation, The University of Chicago, Chicago, Illinois., Moroney JW; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, The University of Chicago, Chicago, Illinois., Ratain MJ; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois., Nanda R; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois., Polite BN; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois., Hahn OM; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois., O'Donnell PH; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois., Vokes EE; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois., Kindler HL; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois., Hseu R; Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, Illinois., Janisch LA; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois., Dai J; Department of Medicine, Section of Dermatology, The University of Chicago, Chicago, Illinois., Hoffman MD; Department of Medicine, Section of Dermatology, The University of Chicago, Chicago, Illinois., Weichselbaum RR; Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, Illinois.; Ludwig Center for Metastasis Research, The University of Chicago, Chicago, Illinois., Pitroda SP; Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, Illinois., Chmura SJ; Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, Illinois. corey.c.foster@vumc.org schmura@radonc.uchicago.edu lukejj@upmc.edu., Luke JJ; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. corey.c.foster@vumc.org schmura@radonc.uchicago.edu lukejj@upmc.edu.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Oct 15; Vol. 27 (20), pp. 5510-5518. Date of Electronic Publication: 2021 Jun 24.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Neoplasms*/pathology , Neoplasms*/therapy , Nivolumab*/therapeutic use , Radiosurgery*, Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Combined Modality Therapy ; Neoplasm Staging ; Treatment Outcome

المؤلفون: Luke JJ; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Onderdonk BE; University of Chicago Medicine, Chicago, Illinois., Bhave SR; Cancer Care Group PC, Indianapolis, Indiana., Karrison T; University of Chicago Medicine, Chicago, Illinois., Lemons JM; Radiation Oncology Associates, Dover, New Hampshire., Chang P; University of Chicago Medicine, Chicago, Illinois., Zha Y; University of Chicago Medicine, Chicago, Illinois., Carll T; University of Chicago Medicine, Chicago, Illinois., Krausz T; University of Chicago Medicine, Chicago, Illinois., Huang L; University of Chicago Medicine, Chicago, Illinois., Martinez C; University of Chicago Medicine, Chicago, Illinois., Janisch LA; University of Chicago Medicine, Chicago, Illinois., Hseu RD; University of Chicago Medicine, Chicago, Illinois., Moroney JW; University of Chicago Medicine, Chicago, Illinois., Patel JD; Northwestern Medicine, Chicago, Illinois., Khodarev NN; University of Chicago Medicine, Chicago, Illinois., Salama JK; Duke Health, Durham, North Carolina., Ott PA; Dana-Farber Cancer Institute, Boston, Massachusetts., Fleming GF; University of Chicago Medicine, Chicago, Illinois., Gajewski TF; University of Chicago Medicine, Chicago, Illinois., Weichselbaum RR; University of Chicago Medicine, Chicago, Illinois., Pitroda SP; University of Chicago Medicine, Chicago, Illinois., Chmura SJ; University of Chicago Medicine, Chicago, Illinois. schmura@radonc.uchicago.edu.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Dec 15; Vol. 26 (24), pp. 6437-6444. Date of Electronic Publication: 2020 Oct 07.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*therapeutic use , Biomarkers, Tumor/*genetics , Chemoradiotherapy/*mortality , Neoplasms/*mortality , Radiosurgery/*mortality, Antineoplastic Agents, Immunological/therapeutic use ; Female ; Gene Expression Profiling ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasms/genetics ; Neoplasms/pathology ; Neoplasms/therapy ; Prognosis ; Survival Rate

المؤلفون: Ramírez J; Department of Medicine, University of Chicago, Chicago, IL, USA., House LK; Department of Medicine, University of Chicago, Chicago, IL, USA., Karrison TG; Department of Public Health Sciences, University of Chicago, Chicago, IL, USA.; Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA., Janisch LA; Department of Medicine, University of Chicago, Chicago, IL, USA., Turcich M; Department of Medicine, University of Chicago, Chicago, IL, USA., Salgia R; Department of Medicine, University of Chicago, Chicago, IL, USA.; Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA., Ratain MJ; Department of Medicine, University of Chicago, Chicago, IL, USA.; Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.; Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, IL, USA., Sharma MR; Department of Medicine, University of Chicago, Chicago, IL, USA.; Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.; Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, IL, USA.

المصدر: Journal of clinical pharmacology [J Clin Pharmacol] 2019 Dec; Vol. 59 (12), pp. 1632-1640. Date of Electronic Publication: 2019 Jul 05.

نوع المنشور: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Capecitabine/*pharmacokinetics , Celecoxib/*pharmacokinetics , Cytochrome P-450 CYP2C9/*metabolism, Adult ; Aged ; Aged, 80 and over ; Area Under Curve ; Drug Interactions/physiology ; Female ; Humans ; Male ; Middle Aged